453.09MMarket Cap
LossP/E TTM
ProKidney Corp's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of ProKidney Corp is 8.17, ranking 167 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.85, which is -70.06% below the recent high of -0.85 and -677.83% above the recent low of -22.16.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.